Revolution Medicines Trademark Renewal

ChangeBridge: Trademarks - Medical Services (Class 044)

Published March 25th, 2026

Detected March 26th, 2026

Summary

The USPTO has renewed the trademark 'Revolution Medicines' (TM98222647) for pharmaceutical preparations and related services. The renewal is effective March 25, 2026, and covers services including drug discovery and providing medical information online.

View original document View source feed page

What changed

This document confirms the renewal of the USPTO trademark 'Revolution Medicines' (TM98222647), effective March 25, 2026. The trademark covers a range of services related to pharmaceutical preparations for oncological and immune system diseases, including drug discovery, research and development, and providing medical and health information via a website.

This is a routine trademark renewal and does not impose new regulatory obligations. Companies should ensure their own intellectual property portfolios are up-to-date and that they are not infringing on existing trademarks. No specific compliance actions are required based on this notice.

Source document (simplified)

← USPTO Trademark Applications

REVOLUTION MEDICINES

Renewed TM98222647 Kind: renewed Mar 25, 2026

Abstract

Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disorders; Pharmaceutical research and development; drug discovery services; providing information about medical and scientific research via a website; Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disorders